Oncology Reports

Papers
(The H4-Index of Oncology Reports is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
[Corrigendum] Highly sensitive detection of leukemia cells based on aptamer and quantum dots160
[Retracted] SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway133
Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro113
Role of miRNA‑214‑3p in cancer (Review)99
Andrographis exerts antitumor effects and enhances 5‑FU efficacy via the alteration of ferroptosis‑related genes in esophageal squamous cell carcinoma86
[Retracted] Overexpression of miR‑203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf‑151
[Retracted] miR‑489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways47
[Corrigendum] Hypoxia and macrophages promote glioblastoma invasion by the CCL4‑CCR5 axis44
[Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK44
Loss of CD24 promotes radiation‑ and chemo‑resistance by inducing stemness properties associated with a hybrid E/M state in breast cancer cells40
[Expression of Concern] Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation36
ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment35
GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis31
Transitioning from molecular methods to therapeutic methods: An in‑depth analysis of glioblastoma (Review)31
Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)28
NR4A1 mediates chemotherapy‑induced senescence via the PI3K/AKT pathway in gastric cancer cells28
Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review)27
[Corrigendum] Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro27
[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer26
Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair26
Evaluation of HMGB1 as possible marker via breast organoid cultures research25
ACSBG1‑driven lipid reprogramming unveiled: A fatty acid metabolism‑associated prognostic model for lung adenocarcinoma24
Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways23
[Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro­environment23
PTP4A1 promotes intrahepatic cholangiocarcinoma development and progression by interacting with PTEN and activating the PI3K/AKT/GSKα axis23
Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice23
0.089461088180542